News · 26 weeks22-33%
2025-10-262026-04-19
Mix990d
- Other4(44%)
- SEC Filings3(33%)
- Leadership1(11%)
- Insider1(11%)
Latest news
25 items- INSIDERSEC Form 4 filed by Shiv Sagiv4 - Marpai, Inc. (0001844392) (Issuer)
- PRMarpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth NationwideTAMPA, Fla., April 1, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced the execution of what the Company believes is its largest to date definitive marketing agreement with a leading healthcare solutions provider. This strategic collaboration is designed to scale the reach of MarpaiRx, Marpai's pharmacy benefit management (PBM) services, across a vast network of self-insured employer groups and third-party administrators.Under the terms of the three-year agreement, the team will leverage its extensive domestic and internati
- SECSEC Form 10-K filed by Marpai Inc.10-K - Marpai, Inc. (0001844392) (Filer)
- SECMarpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Marpai, Inc. (0001844392) (Filer)
- PRMarpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered LivesMarketing Agreement Establishes Powerful National Distribution Channel and Expands Marpai's Revenue Growth OpportunityTAMPA, Fla., March 9, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced the execution of a transformational marketing agreement dramatically expanding the national reach of its high-growth pharmacy benefit management division, providing access to a network representing up to 1.5 million covered employees for MarpaiRx.The agreement creates a powerful new distribution channel for MarpaiRx's pharmacy benefit sol
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Marpai Inc.SCHEDULE 13G/A - Marpai, Inc. (0001844392) (Subject)
- PRMarpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform ExpansionNew Client Momentum Highlights Rapid Adoption of Marpai's Disruptive, Scalable Healthcare Platform Positioned to Drive Exponential Revenue Growth and Long-Term Shareholder ValueTAMPA, Fla., Feb. 23, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced two significant strategic client wins for its high-growth MarpaiRx division, adding more than 19,000 covered lives and further accelerating the Company's expansion as a next-generation healthcare platform.We believe that these wins represent strong validation of Marpai's different
- SECMarpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Marpai, Inc. (0001844392) (Filer)
- PRMARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTHTAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With
- SECMarpai Inc. filed SEC Form 8-K: Leadership Update, Entry into a Material Definitive Agreement8-K - Marpai, Inc. (0001844392) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Marpai Inc.SCHEDULE 13G/A - Marpai, Inc. (0001844392) (Subject)
- SECMarpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Marpai, Inc. (0001844392) (Filer)
- PRMARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSIONRenews Aetna Signature Administrator Network Agreement and Enhances Cost Containment with Faircost Optimizer TAMPA, Fla., Dec. 1, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced significant positive momentum heading into the new year, highlighted by a better-than-expected sales cycle for 2026 and the renewal of its critical network access agreement with Aetna. The Company reports a robust sales cycle, securing a volume of new clients for January 1, 2026, that surpasses internal expectations, reinforcing its path to scalable growt
- PRMARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTSContinued Turnaround Driven by Cost Discipline and Operational Efficiency; Positioned for Strong 2026 Growth TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, announced third quarter 2025 results that mark another quarter of significant operational and financial improvement, underscoring the success of its transformation strategy and the Company's emergence as a disciplined, scalable growth platform heading into 2026. For the third quarter ended September 30, 2025, Marpai continued its turnaround trajectory, achieving meaningful advances in cost control,
- SECSEC Form 10-Q filed by Marpai Inc.10-Q - Marpai, Inc. (0001844392) (Filer)
- SECMarpai Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Marpai, Inc. (0001844392) (Filer)
- INSIDERDirector Eitan Yaron bought $100,000 worth of shares (100,000 units at $1.00), increasing direct ownership by 10% to 1,089,073 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERDirector Shiv Sagiv bought $50,000 worth of shares (50,000 units at $1.00), increasing direct ownership by 23% to 272,000 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERChief Operating Officer Scrip Dallas was granted 100,000 shares (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERDirector Pons Robert M bought $50,000 worth of shares (50,000 units at $1.00), increasing direct ownership by 16% to 359,200 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- SECMarpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Marpai, Inc. (0001844392) (Filer)
- PRMARPAI TO HOST WEBCAST ON NOVEMBER 13, 2025 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTSTAMPA, Fla., Nov. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services. The Company will host a conference call and webcast on Thursday, November 13 at 8:30 a.m. ET to present the Company's operational and financial highlights for Q3 2025. The Company will report its third quarter 2025 results on Wednesday after the market close. Event: Marpai 2025 Q3 Financial Results Conference Call Date: November 13, 2025 Time: 8:30 a.m. Eastern Time Call: US: 1-646-357-8785 / Toll Free: 1-800-836-8184 Webcast: https://app.webinar.net/934VMynbB6a Follow us on X.com and LinkedIn You may str
- INSIDERChief Executive Officer Lamendola Damien was granted 550,000 shares, increasing direct ownership by 69% to 1,350,000 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERDirector Shiv Sagiv was granted 75,000 shares, increasing direct ownership by 51% to 222,000 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERDirector Eitan Yaron was granted 125,000 shares, increasing direct ownership by 14% to 989,073 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)